Skip to main content
Top
Published in: Endocrine 1/2013

01-08-2013 | Original Article

Left ventricular synchronicity is impaired in patients with active acromegaly

Authors: Abdulkadir Kırış, Cihangir Erem, Oğuzhan Ekrem Turan, Nadim Civan, Gülhanım Kırış, İrfan Nuhoğlu, Abdulselam İlter, Halil Önder Ersöz, Merih Kutlu

Published in: Endocrine | Issue 1/2013

Login to get access

Abstract

Acromegaly is associated with a variety of cardiovascular disturbances such as left ventricular hypertrophy, diastolic cardiac dysfunction, and hypertension. Left ventricular (LV) dyssynchrony means the impairment of synchronicity and is defined as the loss of the simultaneous peak contraction of corresponding cardiac segments. The objective of this study was to investigate whether acromegalic patients have left ventricular dyssynchrony. Dyssynchrony was evaluated in 30 patients with active acromegaly and 30 controls. All the patients and controls were subjected to a tissue synchronization imaging. The time to regional peak systolic tissue velocity (Ts) in LV by the six-basal-six-mid-segmental model was measured on ejection phase TSI images and four TSI parameters of systolic dyssynchrony were computed. All TSI parameters of LV dyssynchrony increased in patients with acromegaly compared to the controls: the standard deviation (SD) of the 12 LV segments Ts (43.5 ± 13.5 vs 26.2 ± 12.5, p < 0.001); the maximal difference in Ts between any 2 of the 12 LV segments (133.3 ± 38 vs 84.6 ± 37.6, p < 0.001); the SD of the 6 basal LV segments (41.1 ± 15.9 vs 25.4 ± 14.8, p = 0.001); and the maximal difference in Ts between any 2 of the 6 basal LV segments (102.6 ± 37.5 vs 65.2 ± 36.9, p = 0.001). In addition, there were significant relationships between the levels of growth hormone/insulin-like growth factor-1 and Ts-SD-12. LV synchronicity has been impaired in patients with acromegaly. Left ventricular dyssynchrony is associated with disease activity and it may contribute to the harmful cardiovascular effects of acromegaly.
Literature
1.
go back to reference J.T. Lie, Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. Am. Heart J. 100, 41–52 (1980)PubMedCrossRef J.T. Lie, Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. Am. Heart J. 100, 41–52 (1980)PubMedCrossRef
2.
go back to reference D. Morvan, M. Komajda, A. Grimaldi, G. Turpin, Y. Grosgogeat, Cardiac hypertrophy and function in asymptomatic acromegaly. Eur. Heart J. 12, 666–672 (1991)PubMed D. Morvan, M. Komajda, A. Grimaldi, G. Turpin, Y. Grosgogeat, Cardiac hypertrophy and function in asymptomatic acromegaly. Eur. Heart J. 12, 666–672 (1991)PubMed
3.
go back to reference G. Minniti, M.L. Jaffrain-Rea, C. Moroni, R. Baldelli, E. Ferretti, R. Cassone, A. Gulino, G. Tamburrano, Echocardiographic evidence for a direct effect of GH/IGF-I hypersecretion on cardiac mass and function in young acromegalics. Clin. Endocrinol. (Oxf) 49, 101–106 (1998)CrossRef G. Minniti, M.L. Jaffrain-Rea, C. Moroni, R. Baldelli, E. Ferretti, R. Cassone, A. Gulino, G. Tamburrano, Echocardiographic evidence for a direct effect of GH/IGF-I hypersecretion on cardiac mass and function in young acromegalics. Clin. Endocrinol. (Oxf) 49, 101–106 (1998)CrossRef
4.
go back to reference G. Vitale, M. Galderisi, R. Pivonello, L. Spinelli, A. Ciccarelli, O. de Divitiis, G. Lombardi, A. Colao, Prevalence and determinants of left ventricular hypertrophy in acromegaly: impact of different methods of indexing left ventricular mass. Clin. Endocrinol. (Oxf) 60, 343–349 (2004)CrossRef G. Vitale, M. Galderisi, R. Pivonello, L. Spinelli, A. Ciccarelli, O. de Divitiis, G. Lombardi, A. Colao, Prevalence and determinants of left ventricular hypertrophy in acromegaly: impact of different methods of indexing left ventricular mass. Clin. Endocrinol. (Oxf) 60, 343–349 (2004)CrossRef
5.
go back to reference M. Baykan, C. Erem, O. Gedikli, A. Hacihasanoğlu, T. Erdoğan, M. Koçak, S. Kaplan, A. Kırış, S. Celik, Assessment of the Tei index by tissue Doppler imaging in patients with acromegaly: serum growth hormone level is associated with the Tei index. Echocardiography 25, 374–380 (2008)PubMedCrossRef M. Baykan, C. Erem, O. Gedikli, A. Hacihasanoğlu, T. Erdoğan, M. Koçak, S. Kaplan, A. Kırış, S. Celik, Assessment of the Tei index by tissue Doppler imaging in patients with acromegaly: serum growth hormone level is associated with the Tei index. Echocardiography 25, 374–380 (2008)PubMedCrossRef
7.
go back to reference A. Colao, P. Marzullo, A. Cuocolo, L. Spinelli, R. Pivonello, D. Bonaduce, M. Salvatore, G. Lombardi, Reversal of acromegalic cardiomyopathy in young but not in middle-aged patients after 12 months of treatment with the depot long-acting somatostatin analogue octreotide. Clin. Endocrinol. (Oxf) 58, 169–176 (2003)CrossRef A. Colao, P. Marzullo, A. Cuocolo, L. Spinelli, R. Pivonello, D. Bonaduce, M. Salvatore, G. Lombardi, Reversal of acromegalic cardiomyopathy in young but not in middle-aged patients after 12 months of treatment with the depot long-acting somatostatin analogue octreotide. Clin. Endocrinol. (Oxf) 58, 169–176 (2003)CrossRef
8.
go back to reference G. Vitale, R. Pivonello, R.S. Auriemma, E. Guerra, F. Milone, S. Savastano, G. Lombardi, A. Colao, Hypertension in acromegaly and in the normal population: prevalence and determinants. Clin. Endocrinol. (Oxf) 63, 470–476 (2005)CrossRef G. Vitale, R. Pivonello, R.S. Auriemma, E. Guerra, F. Milone, S. Savastano, G. Lombardi, A. Colao, Hypertension in acromegaly and in the normal population: prevalence and determinants. Clin. Endocrinol. (Oxf) 63, 470–476 (2005)CrossRef
9.
go back to reference P. Maison, P. Démolis, J. Young, G. Schaison, J.F. Giudicelli, P. Chanson, Vascular reactivity in acromegalic patients: preliminary evidence for regional endothelial dysfunction and increased sympathetic vasoconstriction. Clin. Endocrinol. (Oxf) 53, 445–451 (2000)CrossRef P. Maison, P. Démolis, J. Young, G. Schaison, J.F. Giudicelli, P. Chanson, Vascular reactivity in acromegalic patients: preliminary evidence for regional endothelial dysfunction and increased sympathetic vasoconstriction. Clin. Endocrinol. (Oxf) 53, 445–451 (2000)CrossRef
10.
go back to reference A. Giustina, E. Boni, G. Romanelli, V. Grassi, G. Giustina, Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide. Am. J. Cardiol. 15, 1042–1047 (1995)CrossRef A. Giustina, E. Boni, G. Romanelli, V. Grassi, G. Giustina, Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide. Am. J. Cardiol. 15, 1042–1047 (1995)CrossRef
11.
go back to reference A. Frustaci, C. Chimenti, M. Setoguchi, S. Guerra, S. Corsello, F. Crea, A. Leri, J. Kajstura, P. Anversa, A. Maseri, Cell death in acromegalic cardiomyopathy. Circulation 99, 1426–1434 (1999)PubMedCrossRef A. Frustaci, C. Chimenti, M. Setoguchi, S. Guerra, S. Corsello, F. Crea, A. Leri, J. Kajstura, P. Anversa, A. Maseri, Cell death in acromegalic cardiomyopathy. Circulation 99, 1426–1434 (1999)PubMedCrossRef
12.
go back to reference L. Saccà, A. Cittadini, S. Fazio, Growth hormone and the heart. Endocr. Rev. 15, 555–573 (1994)PubMed L. Saccà, A. Cittadini, S. Fazio, Growth hormone and the heart. Endocr. Rev. 15, 555–573 (1994)PubMed
13.
go back to reference R. Lieberman, L. Padeletti, J. Schreuder, K. Jackson, A. Michelucci, A. Colella, W. Eastman, S. Valsecchi, D.A. Hettrick, Ventricular pacing lead location alters systemic hemodynamics and left ventricular function in patients with and without reduced ejection fraction. J. Am. Coll. Cardiol. 48, 1634–1641 (2006)PubMedCrossRef R. Lieberman, L. Padeletti, J. Schreuder, K. Jackson, A. Michelucci, A. Colella, W. Eastman, S. Valsecchi, D.A. Hettrick, Ventricular pacing lead location alters systemic hemodynamics and left ventricular function in patients with and without reduced ejection fraction. J. Am. Coll. Cardiol. 48, 1634–1641 (2006)PubMedCrossRef
14.
go back to reference H. Bader, S. Garrigue, S. Lafitte, S. Reuter, P. Jaïs, M. Haïssaguerre, J. Bonnet, J. Clementy, R. Roudaut, Intra-left ventricular electromechanical asynchrony. A new independent predictor of severe cardiac events in heart failure patients. J. Am. Coll. Cardiol. 43, 248–256 (2004)PubMedCrossRef H. Bader, S. Garrigue, S. Lafitte, S. Reuter, P. Jaïs, M. Haïssaguerre, J. Bonnet, J. Clementy, R. Roudaut, Intra-left ventricular electromechanical asynchrony. A new independent predictor of severe cardiac events in heart failure patients. J. Am. Coll. Cardiol. 43, 248–256 (2004)PubMedCrossRef
15.
go back to reference C. Alonso, C. Leclercq, F. Victor, H. Mansour, C. de Place, D. Pavin, F. Carré, P. Mabo, J.C. Daubert, Electrocardiographic predictive factors of long-term clinical improvement with multisite biventricular pacing in advanced heart failure. Am. J. Cardiol. 84, 1417–1421 (1990)CrossRef C. Alonso, C. Leclercq, F. Victor, H. Mansour, C. de Place, D. Pavin, F. Carré, P. Mabo, J.C. Daubert, Electrocardiographic predictive factors of long-term clinical improvement with multisite biventricular pacing in advanced heart failure. Am. J. Cardiol. 84, 1417–1421 (1990)CrossRef
16.
go back to reference S. Kaplan, A. Kırış, C. Erem, T. Kaplan, G. Kırış, O. Gedikli, M. Koçak, M. Baykan, S. Celik, Assessment of left ventricular systolic asynchrony in patients with clinical hypothyroidism. Echocardiography 27, 117–122 (2010)PubMedCrossRef S. Kaplan, A. Kırış, C. Erem, T. Kaplan, G. Kırış, O. Gedikli, M. Koçak, M. Baykan, S. Celik, Assessment of left ventricular systolic asynchrony in patients with clinical hypothyroidism. Echocardiography 27, 117–122 (2010)PubMedCrossRef
17.
go back to reference A. Kırış, C. Erem, G. Kırış, M. Koçak, O. Gedikli, I. Nuhoğlu, M. Kutlu, T. Kaplan, M. Gökçe, S. Celik, Intra-left ventricular systolic asynchrony in patients with overt hyperthyroidism. Endocrine 38, 283–288 (2010)PubMedCrossRef A. Kırış, C. Erem, G. Kırış, M. Koçak, O. Gedikli, I. Nuhoğlu, M. Kutlu, T. Kaplan, M. Gökçe, S. Celik, Intra-left ventricular systolic asynchrony in patients with overt hyperthyroidism. Endocrine 38, 283–288 (2010)PubMedCrossRef
18.
go back to reference A. Kırış, C. Erem, G. Kırış, I. Nuhoğlu, K. Karaman, N. Civan, C. Örem, I. Durmuş, M. Kutlu, The assessment of left ventricular systolic asynchrony in patients with primary hyperparathyroidism. Echocardiography 28, 955–960 (2011)PubMedCrossRef A. Kırış, C. Erem, G. Kırış, I. Nuhoğlu, K. Karaman, N. Civan, C. Örem, I. Durmuş, M. Kutlu, The assessment of left ventricular systolic asynchrony in patients with primary hyperparathyroidism. Echocardiography 28, 955–960 (2011)PubMedCrossRef
19.
go back to reference G. Korosoglou, P.M. Humpert, E. Halbgewachs, R. Bekeredjian, A. Filusch, S.J. Buss, M. Morcos, A. Bierhaus, H.A. Katus, P.P. Nawroth, H. Kuecherer, Evidence of left ventricular contractile asynchrony by echocardiographic phase imaging in patients with type 2 diabetesmellitus and without clinically evident heart disease. Am. J. Cardiol. 98, P1525–P1530 (2006)CrossRef G. Korosoglou, P.M. Humpert, E. Halbgewachs, R. Bekeredjian, A. Filusch, S.J. Buss, M. Morcos, A. Bierhaus, H.A. Katus, P.P. Nawroth, H. Kuecherer, Evidence of left ventricular contractile asynchrony by echocardiographic phase imaging in patients with type 2 diabetesmellitus and without clinically evident heart disease. Am. J. Cardiol. 98, P1525–P1530 (2006)CrossRef
20.
go back to reference A. Kırış, M. Karkucak, K. Karaman, G. Kırış, E. Capkın, F. Gökmen, M. Kutlu, S. Celik, A. Ayar, Patients with ankylosing spondylitis have evidence of left ventricular asynchrony. Echocardiography 29, 661–667 (2012)PubMedCrossRef A. Kırış, M. Karkucak, K. Karaman, G. Kırış, E. Capkın, F. Gökmen, M. Kutlu, S. Celik, A. Ayar, Patients with ankylosing spondylitis have evidence of left ventricular asynchrony. Echocardiography 29, 661–667 (2012)PubMedCrossRef
21.
go back to reference A. Giustina, A. Barkan, F.F. Casanueva, F. Cavagnini, L. Frohman, K. Ho, J. Veldhuis, J. Wass, K. Von Werder, S. Melmed, Criteria for cure of acromegaly: a consensus statement. J. Clin. Endocrinol. Metab. 85, 526–529 (2000)PubMedCrossRef A. Giustina, A. Barkan, F.F. Casanueva, F. Cavagnini, L. Frohman, K. Ho, J. Veldhuis, J. Wass, K. Von Werder, S. Melmed, Criteria for cure of acromegaly: a consensus statement. J. Clin. Endocrinol. Metab. 85, 526–529 (2000)PubMedCrossRef
22.
go back to reference A. Giustina, P. Chanson, M.D. Bronstein, A. Klibanski, S. Lamberts, F.F. Casanueva, P. Trainer, E. Ghigo, K. Ho, S. Melmed, Acromegaly consensus group. A consensus on criteria for cure of acromegaly. J. Clin. Endocrinol. Metab. 95, 3141–3148 (2010)PubMedCrossRef A. Giustina, P. Chanson, M.D. Bronstein, A. Klibanski, S. Lamberts, F.F. Casanueva, P. Trainer, E. Ghigo, K. Ho, S. Melmed, Acromegaly consensus group. A consensus on criteria for cure of acromegaly. J. Clin. Endocrinol. Metab. 95, 3141–3148 (2010)PubMedCrossRef
23.
go back to reference M.W. Elmlinger, W. Kühnel, M.M. Weber, M.B. Ranke, Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3). Clin. Chem. Lab. Med. 42(6), 654–664 (2004)PubMedCrossRef M.W. Elmlinger, W. Kühnel, M.M. Weber, M.B. Ranke, Reference ranges for two automated chemiluminescent assays for serum insulin-like growth factor I (IGF-I) and IGF-binding protein 3 (IGFBP-3). Clin. Chem. Lab. Med. 42(6), 654–664 (2004)PubMedCrossRef
24.
go back to reference C.M. Yu, Q. Zhang, J.W. Fung, H.C. Chan, Y.S. Chan, G.W. Yip, S.L. Kong, H. Lin, Y. Zhang, J.E. Sanderson, A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging. J. Am. Coll. Cardiol. 45, 677–684 (2005)PubMedCrossRef C.M. Yu, Q. Zhang, J.W. Fung, H.C. Chan, Y.S. Chan, G.W. Yip, S.L. Kong, H. Lin, Y. Zhang, J.E. Sanderson, A novel tool to assess systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging. J. Am. Coll. Cardiol. 45, 677–684 (2005)PubMedCrossRef
25.
go back to reference C. Shub, A.L. Klein, P.K. Zachariah, K.R. Bailey, A.J. Tajik, Determination of left ventricular mass by echocardiography in a normal population: effect of age and sex in addition to body size. Mayo Clin. Proc. 69, 205–211 (1994)PubMedCrossRef C. Shub, A.L. Klein, P.K. Zachariah, K.R. Bailey, A.J. Tajik, Determination of left ventricular mass by echocardiography in a normal population: effect of age and sex in addition to body size. Mayo Clin. Proc. 69, 205–211 (1994)PubMedCrossRef
26.
go back to reference C. Tei, L.H. Ling, D.O. Hodge, K.R. Bailey, J.K. Oh, R.J. Rodeheffer, A.J. Tajik, J.B. Seward, New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function–a study in normals and dilated cardiomyopathy. J. Cardiol. 26, 357–366 (1995)PubMed C. Tei, L.H. Ling, D.O. Hodge, K.R. Bailey, J.K. Oh, R.J. Rodeheffer, A.J. Tajik, J.B. Seward, New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function–a study in normals and dilated cardiomyopathy. J. Cardiol. 26, 357–366 (1995)PubMed
27.
go back to reference J.M. Bland, D.G. Altman, Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1, 307–310 (1986)PubMedCrossRef J.M. Bland, D.G. Altman, Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1, 307–310 (1986)PubMedCrossRef
28.
go back to reference J.M. Bland, D.G. Altman, Measuring agreement in method comparison studies. Stat. Methods Med. Res. 8, 135–160 (1999)PubMedCrossRef J.M. Bland, D.G. Altman, Measuring agreement in method comparison studies. Stat. Methods Med. Res. 8, 135–160 (1999)PubMedCrossRef
29.
go back to reference G. Mercuro, S. Zoncu, P. Colonna, P. Cherchi, S. Mariotti, F. Pigliaru, L. Petrini, S. Iliceto, Cardiac dysfunction in acromegaly: evidence by pulsed wave tissue Doppler imaging. Eur. J. Endocrinol. 143, 363–369 (2000)PubMedCrossRef G. Mercuro, S. Zoncu, P. Colonna, P. Cherchi, S. Mariotti, F. Pigliaru, L. Petrini, S. Iliceto, Cardiac dysfunction in acromegaly: evidence by pulsed wave tissue Doppler imaging. Eur. J. Endocrinol. 143, 363–369 (2000)PubMedCrossRef
30.
go back to reference G. Morton, Burt, K.Y. Ken, Ho, Comparison of efficacy and tolerability of somatostatin analogs and other therapies for acromegaly. Endocrine 20, 299–305 (2003)CrossRef G. Morton, Burt, K.Y. Ken, Ho, Comparison of efficacy and tolerability of somatostatin analogs and other therapies for acromegaly. Endocrine 20, 299–305 (2003)CrossRef
31.
go back to reference V. Bozok Cetintas, A. Zengi, A. Tetik, M. Karadeniz, F. Ergonen, A.S. Kucukaslan, S. Tamsel, B. Kosova, S.B. Sahin, F. Saygılı, Z. Eroglu, Does apolipoprotein E genotype affect cardiovascular risk in subjects with acromegaly? Endocrine 41, 465–472 (2012)PubMedCrossRef V. Bozok Cetintas, A. Zengi, A. Tetik, M. Karadeniz, F. Ergonen, A.S. Kucukaslan, S. Tamsel, B. Kosova, S.B. Sahin, F. Saygılı, Z. Eroglu, Does apolipoprotein E genotype affect cardiovascular risk in subjects with acromegaly? Endocrine 41, 465–472 (2012)PubMedCrossRef
32.
go back to reference A. Shefer, Y. Rozenman, Y. Ben David, M.Y. Flugelman, M.S. Gotsman, B.S. Lewis, Left ventricular function during physiological cardiac pacing: relation to rate, pacing mode, and underlying myocardial disease. Pacing Clin. Electrophysiol. 10, 315–332 (1987)PubMedCrossRef A. Shefer, Y. Rozenman, Y. Ben David, M.Y. Flugelman, M.S. Gotsman, B.S. Lewis, Left ventricular function during physiological cardiac pacing: relation to rate, pacing mode, and underlying myocardial disease. Pacing Clin. Electrophysiol. 10, 315–332 (1987)PubMedCrossRef
33.
go back to reference T.A. Buckingham, Right ventricular outflow tract pacing. Pacing Clin. Electrophysiol. 20, 1237–1242 (1997)PubMedCrossRef T.A. Buckingham, Right ventricular outflow tract pacing. Pacing Clin. Electrophysiol. 20, 1237–1242 (1997)PubMedCrossRef
34.
go back to reference T.M. Kolettis, Z.S. Kyriakides, D. Tsiapras, T. Popov, I.A. Paraskevaides, D.T. Kremastinos, Improved left ventricular relaxation during short-term right ventricular outflow tract compared to apical pacing. Chest 117, 60–64 (2000)PubMedCrossRef T.M. Kolettis, Z.S. Kyriakides, D. Tsiapras, T. Popov, I.A. Paraskevaides, D.T. Kremastinos, Improved left ventricular relaxation during short-term right ventricular outflow tract compared to apical pacing. Chest 117, 60–64 (2000)PubMedCrossRef
35.
go back to reference G.S. Nelson, C.W. Curry, B.T. Wyman, A. Kramer, J. Declerck, M. Talbot, M.R. Douglas, R.D. Berger, E.R. McVeigh, D.A. Kass, Predictors of systolic augmentation from left ventricular pre-excitation in patients with dilated cardiomyopathy and intraventricular conduction delay. Circulation 101, 2703–2709 (2000)PubMedCrossRef G.S. Nelson, C.W. Curry, B.T. Wyman, A. Kramer, J. Declerck, M. Talbot, M.R. Douglas, R.D. Berger, E.R. McVeigh, D.A. Kass, Predictors of systolic augmentation from left ventricular pre-excitation in patients with dilated cardiomyopathy and intraventricular conduction delay. Circulation 101, 2703–2709 (2000)PubMedCrossRef
36.
go back to reference C.M. Yu, W.H. Fung, H. Lin, Q. Zhang, J.E. Sanderson, C.P. Lau, Predictors of left ventricular reverse remodelling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am. J. Cardiol. 91, 684–688 (2003)PubMedCrossRef C.M. Yu, W.H. Fung, H. Lin, Q. Zhang, J.E. Sanderson, C.P. Lau, Predictors of left ventricular reverse remodelling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am. J. Cardiol. 91, 684–688 (2003)PubMedCrossRef
37.
go back to reference J.J. Bax, G.B. Bleeker, T.H. Marwick, S.G. Molhoek, E. Boersma, P. Steendijk, E.E. van der Wall, M.J. Schalji, Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J. Am. Coll. Cardiol. 44, 1834–1840 (2004)PubMedCrossRef J.J. Bax, G.B. Bleeker, T.H. Marwick, S.G. Molhoek, E. Boersma, P. Steendijk, E.E. van der Wall, M.J. Schalji, Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J. Am. Coll. Cardiol. 44, 1834–1840 (2004)PubMedCrossRef
38.
go back to reference A. Kırış, K. Karaman, G. Kırış, M. Sahin, I. Durmuş, S. Kaplan, A. Orem, M. Kutlu, A. Ayar, Left ventricular dyssynchrony and its effects on cardiac function in patients with newly diagnosed hypertension. Echocardiography 29, 914–922 (2012)PubMedCrossRef A. Kırış, K. Karaman, G. Kırış, M. Sahin, I. Durmuş, S. Kaplan, A. Orem, M. Kutlu, A. Ayar, Left ventricular dyssynchrony and its effects on cardiac function in patients with newly diagnosed hypertension. Echocardiography 29, 914–922 (2012)PubMedCrossRef
39.
go back to reference H.W. Tan, G.L. Zheng, L. Li, Z.H. Wang, H.P. Gong, Y. Zhang, M. Zhong, W. Zhang, Impaired left ventricular synchronicity in hypertensive patients with ventricular hypertrophy. J. Hypertens. 26, 553–559 (2008)PubMedCrossRef H.W. Tan, G.L. Zheng, L. Li, Z.H. Wang, H.P. Gong, Y. Zhang, M. Zhong, W. Zhang, Impaired left ventricular synchronicity in hypertensive patients with ventricular hypertrophy. J. Hypertens. 26, 553–559 (2008)PubMedCrossRef
40.
go back to reference W. Komsala, W. Kucharski, M. Przewlocka-Kosmala, W. Mazurek, Comparison of left ventricular function by tissue Doppler imaging in patients with diabetes mellitus without systemic hypertension versus diabetes mellitus with systemic hypertension. Am. J. Cardiol. 94, 395–399 (2004)CrossRef W. Komsala, W. Kucharski, M. Przewlocka-Kosmala, W. Mazurek, Comparison of left ventricular function by tissue Doppler imaging in patients with diabetes mellitus without systemic hypertension versus diabetes mellitus with systemic hypertension. Am. J. Cardiol. 94, 395–399 (2004)CrossRef
41.
go back to reference F. Bogazzi, V. Di Bello, C. Palagi, M.G. Donne, A. Di Cori, S. Gavioli, E. Talini, C. Cosci, C. Sardella, S. Brogioni, M. Mariani, E. Martino, Improvement of intrinsic myocardial contractility and cardiac fibrosis degree in acromegalic patients treated with somatostatin analogues: a prospective study. Clin. Endocrinol. (Oxf) 62, 590–596 (2005)CrossRef F. Bogazzi, V. Di Bello, C. Palagi, M.G. Donne, A. Di Cori, S. Gavioli, E. Talini, C. Cosci, C. Sardella, S. Brogioni, M. Mariani, E. Martino, Improvement of intrinsic myocardial contractility and cardiac fibrosis degree in acromegalic patients treated with somatostatin analogues: a prospective study. Clin. Endocrinol. (Oxf) 62, 590–596 (2005)CrossRef
42.
go back to reference M.M. Ciulla, P. Epaminonda, R. Paliotti, M.V. Barelli, C. Ronchi, V. Cappiello, A. Sartorio, V. Buonamici, F. Magrini, P. Beck-Peccoz, M. Arosio, Evaluation of cardiac structure by echoreflectivity analysis in acromegaly: effects of treatment. Eur. J. Endocrinol. 151, 179–186 (2004)PubMedCrossRef M.M. Ciulla, P. Epaminonda, R. Paliotti, M.V. Barelli, C. Ronchi, V. Cappiello, A. Sartorio, V. Buonamici, F. Magrini, P. Beck-Peccoz, M. Arosio, Evaluation of cardiac structure by echoreflectivity analysis in acromegaly: effects of treatment. Eur. J. Endocrinol. 151, 179–186 (2004)PubMedCrossRef
43.
go back to reference A. Colao, A. Cuocolo, P. Marzullo, E. Nicolai, D. Ferone, A.M. Della Morte, M. Petretta, M. Salvatore, G. Lombardi, Impact of patient’s age and disease duration on cardiac performance in acromegaly: a radionuclide angiography study. J. Clin. Endocrinol. Metab. 84, 1518–1523 (1999)PubMedCrossRef A. Colao, A. Cuocolo, P. Marzullo, E. Nicolai, D. Ferone, A.M. Della Morte, M. Petretta, M. Salvatore, G. Lombardi, Impact of patient’s age and disease duration on cardiac performance in acromegaly: a radionuclide angiography study. J. Clin. Endocrinol. Metab. 84, 1518–1523 (1999)PubMedCrossRef
Metadata
Title
Left ventricular synchronicity is impaired in patients with active acromegaly
Authors
Abdulkadir Kırış
Cihangir Erem
Oğuzhan Ekrem Turan
Nadim Civan
Gülhanım Kırış
İrfan Nuhoğlu
Abdulselam İlter
Halil Önder Ersöz
Merih Kutlu
Publication date
01-08-2013
Publisher
Springer US
Published in
Endocrine / Issue 1/2013
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-012-9859-9

Other articles of this Issue 1/2013

Endocrine 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.